These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32045593)

  • 1. Inosine prevents hyperlocomotion in a ketamine-induced model of mania in rats.
    Camerini L; Ardais AP; Xavier J; Bastos CR; Oliveira S; Soares MSP; de Mattos BDS; Ávila AA; do Couto CAT; Spanevello RM; Pochmann D; Moritz CEJ; Porciúncula LO; Figueiró F; Kaster MP; Ghisleni G
    Brain Res; 2020 Apr; 1733():146721. PubMed ID: 32045593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blackberry extract improves behavioral and neurochemical dysfunctions in a ketamine-induced rat model of mania.
    Chaves VC; Soares MSP; Spohr L; Teixeira F; Vieira A; Constantino LS; Pizzol FD; Lencina CL; Spanevello RM; Freitas MP; Simões CMO; Reginatto FH; Stefanello FM
    Neurosci Lett; 2020 Jan; 714():134566. PubMed ID: 31698027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 50-kHz ultrasonic vocalizations in animal models of mania: Ketamine and lisdexamfetamine-induced hyperlocomotion in rats.
    Wendler E; de Souza CP; Vecchia DD; Kanazawa LKS; de Almeida Soares Hocayen P; Wöhr M; Schwarting RKW; Andreatini R
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1900-1908. PubMed ID: 27842942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lithium exposure attenuates ketamine-induced mania-like behavior and c-Fos expression in the forebrain of mice.
    Gao TH; Ni RJ; Liu S; Tian Y; Wei J; Zhao L; Wang Q; Ni P; Ma X; Li T
    Pharmacol Biochem Behav; 2021 Mar; 202():173108. PubMed ID: 33450292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.
    Cunha MP; Pazini FL; Rosa JM; Ramos-Hryb AB; Oliveira Á; Kaster MP; Rodrigues AL
    Purinergic Signal; 2015 Jun; 11(2):215-27. PubMed ID: 25702084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.
    Kaster MP; Budni J; Gazal M; Cunha MP; Santos AR; Rodrigues AL
    Purinergic Signal; 2013 Sep; 9(3):481-6. PubMed ID: 23613131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of behavioral and neurochemical changes induced by ketamine in rats: implications as an animal model of mania.
    Ghedim FV; Fraga Dde B; Deroza PF; Oliveira MB; Valvassori SS; Steckert AV; Budni J; Dal-Pizzol F; Quevedo J; Zugno AI
    J Psychiatr Res; 2012 Dec; 46(12):1569-75. PubMed ID: 22998743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallic acid protects cerebral cortex, hippocampus, and striatum against oxidative damage and cholinergic dysfunction in an experimental model of manic-like behavior: Comparison with lithium effects.
    Recart VM; Spohr L; Soares MSP; de Mattos BDS; Bona NP; Pedra NS; Teixeira FC; Gamaro GD; Stefanello F; Spanevello R
    Int J Dev Neurosci; 2021 Apr; 81(2):167-178. PubMed ID: 33394512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blueberry extract on energetic metabolism, levels of brain-derived neurotrophic factor, and Ca
    Spohr L; Soares MSP; Bona NP; Pedra NS; Barschak AG; Alvariz RM; Vizzotto M; Lencina CL; Stefanello FM; Spanevello RM
    Metab Brain Dis; 2022 Mar; 37(3):835-847. PubMed ID: 35043268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined actions of blueberry extract and lithium on neurochemical changes observed in an experimental model of mania: exploiting possible synergistic effects.
    Spohr L; Soares MSP; Oliveira PS; da Silveira de Mattos B; Bona NP; Pedra NS; Teixeira FC; do Couto CAT; Chaves VC; Reginatto FH; Lisboa MT; Ribeiro AS; Lencina CL; Stefanello FM; Spanevello RM
    Metab Brain Dis; 2019 Apr; 34(2):605-619. PubMed ID: 30535659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of edaravone in ketamine-induced model of mania in rats.
    Arslan FC; Tiryaki A; Yıldırım M; Özkorumak E; Alver A; Altun İK; İnce İ; Gedikli Ö
    Acta Neurobiol Exp (Wars); 2016; 76(3):192-8. PubMed ID: 27685772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive Effect of Cecropia pachystachya Against Ketamine-Induced Manic Behavior and Oxidative Stress in Rats.
    Gazal M; Kaufmann FN; Acosta BA; Oliveira PS; Valente MR; Ortmann CF; Sturbelle R; Lencina CL; Stefanello FM; Kaster MP; Reginatto FH; Ghisleni G
    Neurochem Res; 2015 Jul; 40(7):1421-30. PubMed ID: 25998886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats.
    Gazal M; Valente MR; Acosta BA; Kaufmann FN; Braganhol E; Lencina CL; Stefanello FM; Ghisleni G; Kaster MP
    Eur J Pharmacol; 2014 Feb; 724():132-9. PubMed ID: 24384407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic lithium exposure in a modified rodent ketamine-induced hyperactivity model of mania.
    Krug JT; Klein AK; Purvis EM; Ayala K; Mayes MS; Collins L; Fisher MPA; Ettenberg A
    Pharmacol Biochem Behav; 2019 Apr; 179():150-155. PubMed ID: 30658121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways.
    Nascimento FP; Figueredo SM; Marcon R; Martins DF; Macedo SJ; Lima DA; Almeida RC; Ostroski RM; Rodrigues AL; Santos AR
    J Pharmacol Exp Ther; 2010 Aug; 334(2):590-8. PubMed ID: 20472668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
    Varela RB; Valvassori SS; Lopes-Borges J; Mariot E; Dal-Pont GC; Amboni RT; Bianchini G; Quevedo J
    J Psychiatr Res; 2015 Feb; 61():114-21. PubMed ID: 25467060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of lithium isotopes in a ketamine-induced hyperactivity model of mania.
    Ettenberg A; Ayala K; Krug JT; Collins L; Mayes MS; Fisher MPA
    Pharmacol Biochem Behav; 2020 Mar; 190():172875. PubMed ID: 32084493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of purinergic signaling in depressive disorders.
    Sperlagh B; Csolle C; Ando RD; Goloncser F; Kittel A; Baranyi M
    Neuropsychopharmacol Hung; 2012 Dec; 14(4):231-8. PubMed ID: 23269209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart.
    Robin E; Sabourin J; Marcillac F; Raddatz E
    J Mol Cell Cardiol; 2013 Oct; 63():14-25. PubMed ID: 23837961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain.
    Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
    Behav Brain Res; 2014 Sep; 271():316-24. PubMed ID: 24959861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.